BMI View: Iraq's ailing domestic landscape will dampen investor confidence in the country's
pharmaceuticals and healthcare sectors over at least the next few years if not longer. Although the
government remains committed to healthcare provision, economic and security ..."
BMI View: Heightened political instability in Iraq will pose downside risks to healthcare reconstruction
programs over the short term. In the long term, however, despite the challenging economic and political
environment, Iraq's health sector outlook will remain posit ..."
BMI View: With lower revenues from oil exports and significant costs associated with the battle against
Islamic State, the Iraqi government will continue to face headwinds in providing healthcare to its
population. Furthermore, economic headwinds will also feed throug ..."
BMI View: Iraq's pharmaceutical market will remain unattractive for multinational drugmakers over the
medium term. The government is devoting a greater proportion of fiscal resources to strengthen Iraq's
political and economic institutions, which are currently under a ..."
BMI View: Severe funding shortages have forced the closure of many donor-funded health programmes in
Iraq, leaving a large number of citizens without access to urgently needed health services and medicines.
Furthermore, the sustained weakness in oil prices, coupled wi ..."
BMI View: Iraq's pharmaceutical market will remain an unattractive proposition for multinational
drugmakers in the short-term at least. Lower oil prices and the presence of Islamic State will subdue
government finances, and the cutting of subsidies will negatively imp ..."
BMI View: Iraq's attractiveness as a pharmaceutical market is highly dependent on the security situation in
the country. With the Islamic State (IS) negatively impacting healthcare access in the northern states, Iraq's
pharmaceutical market appeal to foreign investors ..."
BMI View: The competitiveness of Iraq's pharmaceutical sector, as well as the ability of the government to
ramp up healthcare investment, is linked to oil prices and additional foreign investment, which is, in turn,
highly dependent on the security situation. The long ..."
The long-term prospects for the Iraqi pharmaceutical and healthcare markets remain promising given rising
healthcare expenditure as well as further population growth. The Iraqi government has reportedly pledged to
invest USD12bn into healthcare expansions in 2014, and ..."
BMI View: Thanks to the government's expansionary fiscal policy, spending on education, health and
public services will increase. The Iraqi government has reportedly pledged to invest USD12bn into
healthcare expansions in 2014, and the Ministry of Health recently awar ..."